Squarepoint Ops LLC boosted its position in shares of Select Medical Holdings Co. (NYSE:SEM - Free Report) by 460.3% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 242,756 shares of the health services provider's stock after acquiring an additional 199,429 shares during the quarter. Squarepoint Ops LLC owned 0.19% of Select Medical worth $4,576,000 at the end of the most recent reporting period.
A number of other large investors have also recently added to or reduced their stakes in SEM. Norges Bank acquired a new position in Select Medical during the fourth quarter valued at approximately $29,556,000. The Manufacturers Life Insurance Company raised its position in Select Medical by 2,552.7% in the fourth quarter. The Manufacturers Life Insurance Company now owns 1,596,414 shares of the health services provider's stock valued at $30,092,000 after purchasing an additional 1,536,234 shares during the last quarter. Hood River Capital Management LLC increased its holdings in Select Medical by 404.8% in the fourth quarter. Hood River Capital Management LLC now owns 1,755,733 shares of the health services provider's stock worth $33,096,000 after purchasing an additional 1,407,902 shares in the last quarter. Invesco Ltd. lifted its stake in Select Medical by 48.6% in the fourth quarter. Invesco Ltd. now owns 2,643,943 shares of the health services provider's stock valued at $49,838,000 after buying an additional 864,852 shares during the period. Finally, Bridgeway Capital Management LLC acquired a new stake in shares of Select Medical during the 4th quarter worth approximately $14,074,000. Institutional investors and hedge funds own 89.48% of the company's stock.
Select Medical Price Performance
SEM traded up $0.35 during trading on Thursday, hitting $15.01. 954,489 shares of the company traded hands, compared to its average volume of 918,872. The stock's 50-day simple moving average is $15.98 and its two-hundred day simple moving average is $19.39. Select Medical Holdings Co. has a 1 year low of $14.03 and a 1 year high of $40.98. The company has a market cap of $1.93 billion, a PE ratio of 9.09, a P/E/G ratio of 0.64 and a beta of 1.40. The company has a current ratio of 1.13, a quick ratio of 1.13 and a debt-to-equity ratio of 1.37.
Select Medical (NYSE:SEM - Get Free Report) last posted its quarterly earnings results on Thursday, May 1st. The health services provider reported $0.44 EPS for the quarter, missing analysts' consensus estimates of $0.45 by ($0.01). The company had revenue of $1.35 billion during the quarter, compared to the consensus estimate of $1.40 billion. Select Medical had a return on equity of 14.04% and a net margin of 3.23%. The company's revenue for the quarter was down 24.4% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.75 earnings per share. As a group, sell-side analysts anticipate that Select Medical Holdings Co. will post 1.17 earnings per share for the current fiscal year.
Select Medical Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Thursday, May 29th. Shareholders of record on Thursday, May 15th will be given a $0.0625 dividend. The ex-dividend date of this dividend is Thursday, May 15th. This represents a $0.25 dividend on an annualized basis and a dividend yield of 1.67%. Select Medical's dividend payout ratio (DPR) is currently 18.66%.
Select Medical declared that its Board of Directors has approved a stock buyback plan on Thursday, May 1st that authorizes the company to repurchase $1.00 billion in outstanding shares. This repurchase authorization authorizes the health services provider to repurchase up to 42.6% of its stock through open market purchases. Stock repurchase plans are usually a sign that the company's leadership believes its stock is undervalued.
Analysts Set New Price Targets
A number of equities analysts have recently weighed in on SEM shares. Mizuho initiated coverage on Select Medical in a research note on Wednesday, April 16th. They issued an "outperform" rating and a $25.00 target price on the stock. Royal Bank of Canada cut their price objective on Select Medical from $23.00 to $19.00 and set an "outperform" rating on the stock in a research report on Wednesday, May 7th. Wall Street Zen raised Select Medical from a "hold" rating to a "buy" rating in a research report on Friday, February 21st. Finally, Benchmark raised shares of Select Medical from a "hold" rating to a "buy" rating and set a $23.00 price target on the stock in a report on Monday, February 24th. One investment analyst has rated the stock with a hold rating and five have assigned a buy rating to the company's stock. According to data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average price target of $26.00.
Check Out Our Latest Research Report on SEM
Insider Transactions at Select Medical
In other Select Medical news, Director Parvinderjit S. Khanuja purchased 21,000 shares of the stock in a transaction dated Monday, May 5th. The stock was acquired at an average cost of $15.02 per share, for a total transaction of $315,420.00. Following the acquisition, the director now owns 65,089 shares in the company, valued at $977,636.78. This trade represents a 47.63% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO David S. Chernow sold 225,000 shares of Select Medical stock in a transaction dated Monday, April 28th. The shares were sold at an average price of $18.00, for a total value of $4,050,000.00. Following the completion of the transaction, the chief executive officer now directly owns 714,516 shares of the company's stock, valued at approximately $12,861,288. This represents a 23.95% decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 11.60% of the company's stock.
Select Medical Company Profile
(
Free Report)
Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.
Featured Stories

Before you consider Select Medical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Select Medical wasn't on the list.
While Select Medical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report